We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Nihon Kohden

Major product line for clinical diagnostics includes both automatic and semiautomatic hematology analyzers. The produ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Nihon Kohden America Launches New Series of Bedside Monitoring Systems

By HospiMedica International staff writers
Posted on 06 Apr 2022
Print article
Image: Life Scope G5Max is the all-in-one solution ideal for mid/high acuity settings (Photo courtesy of Nihon Kohden America)
Image: Life Scope G5Max is the all-in-one solution ideal for mid/high acuity settings (Photo courtesy of Nihon Kohden America)

Nihon Kohden America (Irvine, CA, USA) has announced the expansion of the Life Scope G Series with the US market introduction of Life Scope G5 and G5Max, a new series of bedside monitoring systems. Created by clinicians, for clinicians- these patient monitors provide more data, more insights, and more efficiency for better patient outcomes.

The advanced features of Life Scope G5 and G5Max combine fully optimized, adaptable monitors with an enterprise level server and software applications customized to the needs of clinicians. With consistent user interfaces that are easy to use and streamline workflows, clinicians are empowered to spend more time with their patients and less with technology.

The Life Scope G5 is configured as an all-in-one system with a transport monitor nested in the back of the unit and is available in a 12.1” display. For a larger high-performance screen, the G5Max is available in 15.6” with a true flat tempered glass front. Both Life Scope G5 and G5Max allow users to configure the alarms to meet their clinical needs and reduce alarm fatigue. The Life Scope G5 and G5Max offer advanced EGG parameter monitoring such as continuous QTc or QRSd, advanced atrial fibrillation algorithm, enhanced review capability ST analysis and event recall.

“Patients are our top priority at Nihon Kohden America, when we succeed, patients everywhere heal faster,” said Eiichi (Eddie) Tanaka, President and CEO at Nihon Kohden America, “We designed the expansion of the Life Scope G Series to help accomplish one critical goal: allow clinicians to spend more time with their patients and less with technology.”

Related Links:
Nihon Kohden America 


Print article

Channels

Surgical Techniques

view channel
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

Esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half a million people annually. Esophageal squamous cell carcinoma (ESCC) comprises 80%... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.